These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 24043456
1. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD. Gálffy G, Mezei G, Németh G, Tamási L, Müller V, Selroos O, Orosz M. Drugs R D; 2013 Sep; 13(3):215-22. PubMed ID: 24043456 [Abstract] [Full Text] [Related]
2. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Müller V, Gálffy G, Orosz M, Kováts Z, Odler B, Selroos O, Tamási L. Int J Chron Obstruct Pulmon Dis; 2016 Sep; 11():93-101. PubMed ID: 26834466 [Abstract] [Full Text] [Related]
6. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler® for Patients with Poorly Controlled Obstructive Airway Disease: a Real-World Study of Patient-Reported Outcomes. Tamási L, Szilasi M, Gálffy G. Adv Ther; 2018 Aug; 35(8):1140-1152. PubMed ID: 30066185 [Abstract] [Full Text] [Related]
7. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®. Syk J, Vinge I, Sörberg M, Vahteristo M, Rytilä P. Adv Ther; 2019 Jul; 36(7):1756-1769. PubMed ID: 30941722 [Abstract] [Full Text] [Related]
8. Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial. Karjalainen J, Vartiainen V, Tikkakoski A, Malmberg LP, Vuotari L, Lähelmä S, Sairanen U, Vahteristo M, Lehtimäki L. Respir Med; 2024 Jul; 230():107693. PubMed ID: 38851404 [Abstract] [Full Text] [Related]
10. Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in Turkey. Öztürk C, Kaya A, Bilgin C, Yücesoy L, İkidağ B, Demirel M, Başlılar Ş, Şaylan B, Senol T, Ağanoğlu S, Can G, Doğrul MI, Çam M, Erdoğan N, Batum Ö, Turan MO, Demir C, Torun Ş, Cirit M, Turan M, Keleşoğlu A, Yaşar S, Uzunay Ö, Melek K, Altıparmak O. Tuberk Toraks; 2012 Jul; 60(4):301-13. PubMed ID: 23289459 [Abstract] [Full Text] [Related]
12. Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler® Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes. Gálffy G, Szilasi M, Tamási L. Pulm Ther; 2019 Dec; 5(2):165-177. PubMed ID: 32026408 [Abstract] [Full Text] [Related]
14. In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial. Jõgi R, Lähelmä S, Vahteristo M, Happonen A, Haikarainen J. J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):88-98. PubMed ID: 30300557 [Abstract] [Full Text] [Related]
15. Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the treatment of histamine-induced bronchoconstriction. Zetterström O, Lähelmä S, Keski-karhu J, Silvasti M, Ostling-kulling E, Ahonen A. Respir Med; 2000 Nov; 94(11):1097-102. PubMed ID: 11127498 [Abstract] [Full Text] [Related]
16. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W, Levine B, Andriano K, Lavecchia C, Yegen U. Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [Abstract] [Full Text] [Related]
17. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer. Dubakiene R, Nargela R, Sakalauskas R, Vahteristo M, Silvasti M, Lähelmä S. Respiration; 2006 Oct; 73(4):441-8. PubMed ID: 16432294 [Abstract] [Full Text] [Related]
18. Application and efficacy of the multi-dose powder inhaler, Easyhaler, in children with asthma. Malmström K, Sorva R, Silvasti M. Pediatr Allergy Immunol; 1999 Feb; 10(1):66-70. PubMed ID: 10410920 [Abstract] [Full Text] [Related]
19. Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: a multicenter, randomized, open-label, parallel-group study. Brambilla C, Le Gros V, Bourdeix I, Efficacy of Foradil in Asthma (EFORA) French Study Group. Clin Ther; 2003 Jul; 25(7):2022-36. PubMed ID: 12946548 [Abstract] [Full Text] [Related]
20. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial. Yildiz P, Bayraktaroglu M, Gorgun D, Yuksel K. Clin Drug Investig; 2019 Oct; 39(10):991-1001. PubMed ID: 31332649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]